Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Sep 15;63(18):2533-2536.
doi: 10.2169/internalmedicine.1701-23. Epub 2024 Mar 4.

Cardiomyopathy with an LMNA Genetic Variant Affecting Three Consecutive Generations: A Case Series

Affiliations
Case Reports

Cardiomyopathy with an LMNA Genetic Variant Affecting Three Consecutive Generations: A Case Series

Naoko Ogawa et al. Intern Med. .

Abstract

We report the case of a family afflicted with cardiac laminopathy who showed atrial fibrillation (AF) and complete atrioventricular block across three generations. Implantable cardioverter defibrillators (ICDs) implantation, or cardiac resynchronization therapy (CRT) were delivered to the three patients (proband; 61 years old, proband's mother: 84 years old, and proband's daughter; 38 years old) to prevent sudden cardiac death or suppress heart failure progression. A novel frameshift mutation (LMNA Exon 9: c.1550dupA;p. N518Efs*34) was found in all three cases through genetic testing, and this mutation may potentially result in the relatively late appearance of a phenotype of left ventricular systolic dysfunction.

Keywords: LMNA cardiomyopathy; atrial fibrillation; atrioventricular block; implantable cardioverter defibrillator; sudden cardiac death.

PubMed Disclaimer

Conflict of interest statement

The authors state that they have no Conflict of Interest (COI).

Figures

Figure 1.
Figure 1.
(A) The family pedigree of laminopathy. The arrow indicates the proband. The filled circles indicate the affected family members. The “+” symbols indicate carriers of the LMNA variant. NPs indicate the individuals who did not take genetic testing. (B) Ventricular fibrillation recorded using intracardiac electrocardiogram. (C) A 12-lead ECG on admission. (D) Echocardiographic findings of the four-chamber (left) and short-axis (right) views at diastole (upper) and systole (lower).
Figure 2.
Figure 2.
(A) Twelve-lead ECG before cardiac resynchronization therapy. (B) Twelve-lead ECG after cardiac resynchronization therapy. (C) Chest radiography after biventricular pacemaker implantation. (D) Echocardiographic findings of the four-chamber (left) and short-axis (right) views at diastole (upper) and systole (lower).
Figure 3.
Figure 3.
(A) Twelve-lead ECG on admission. (B) Echocardiographic findings of the four-chamber (left) and short-axis (right) views at diastole (upper) and systole (lower). (C) Chest radiography on admission. (D) Twelve-lead ECG after catheter ablation for atrial fibrillation. (E) Voltage map of the left atrium (Red, green, yellow, and blue areas show low voltage zone, and purple area shows normal voltage zone). AP depicts anteroposterior; ECG: electrocardiogram, LIPV: left inferior pulmonary vein, LSPV: left superior pulmonary vein, PA: posteroanterior, RSPV: right superior pulmonary vein, RIPV: right inferior pulmonary vein. (F) Sanger sequencing of the proband and family members. Red arrows indicate the inserted A overlapped with G.

Similar articles

Cited by

References

    1. Peretto G, Sala S, Benedetti S, et al. . Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease. Nucleus 9: 380-391, 2018. - PMC - PubMed
    1. Taylor MR, Fain PR, Sinagra G, et al. . Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 41: 771-780, 2003. - PubMed
    1. van Rijsingen IA, Arbustini E, Elliott PM, et al. . Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol 59: 493-500, 2012. - PubMed
    1. Kitaoka H, Tsutsui H, Kubo T, et al. . JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies. Circ J 85: 1590-1689, 2021. - PubMed
    1. Nishiuchi S, Makiyama T, Aiba T, et al. . Gene-based risk stratification for cardiac disorders in LMNA mutation carriers. Circ Cardiovasc Genet 10: e001603, 2017. - PubMed

Publication types